US2010261880A1PendingUtilityA1

Ly6h polypeptide

Assignee: OTSUKA PHARMA CO LTDPriority: Sep 17, 1998Filed: Sep 30, 2008Published: Oct 14, 2010
Est. expirySep 17, 2018(expired)· nominal 20-yr term from priority
A61P 9/10A61P 25/16A61P 25/28C07K 14/705A61K 38/00A61K 48/00C12N 15/11
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides a brain-specific gene useful in treating Alzheimer's disease, for instance, which comprises a nucleotide sequence cording for the amino acid sequence shown in SQ ID NO:1 and fragments thereof; an expression vector comprising the gene; a host cell comprising the expression vector; an expression product of the gene; an antibody against the product; a therapeutic and prophylactic composition for neurodegenerative disease; and the like.

Claims

exact text as granted — not AI-modified
1 . A polypeptide comprising the amino acid sequence of SEQ ID NO:1. 
     
     
         2 . The polypeptide according to  claim 1 , wherein said polypeptide is produced by recombinant technology or chemical synthesis.

Join the waitlist — get patent alerts

Track US2010261880A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.